130 medicines in development for asthma, allergies and other respiratory diseases

Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40 million patients in the U.S. Furthermore, respiratory allergies affect 10 percent of children under the age of 18. Not only do these diseases impact day-to-day functioning, but they can also be life-threatening.
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicines in Development Asthma New Era of Medicine Source Type: news